🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-arm, prospective, multi-center clinical trial. desig...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-12-31
Trial ID
NCT04303130
Treatments Being Tested
To investigate the efficacy and safety of carelizumab combined with regoraf...
Status
Unknown
Location
NanFang Hospital of Southern Medical University
Start Date
2021-05-06
Trial ID
NCT04806243
Treatments Being Tested
The purpose of this study was to evaluate the overall survival time (OS), o...
Status
Unknown
Location
NanFang Hospital
Start Date
2020-05-19
Trial ID
NCT04934618
Treatments Being Tested
This randomized, open-label phase 3 study will evaluate the safety and effi...
Status
Terminated
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2020-07-14
Trial ID
NCT04335006
Treatments Being Tested
To evaluate the efficacy and safety of carelizumab combined with XELOX regi...
Status
Unknown
Location
Wang Nan
Start Date
2023-02-01
Trial ID
NCT05715632
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common malignancy, and its incidence is...
Status
Unknown
Location
Multiple Locations
Start Date
2020-01-10
Trial ID
NCT04193696
Triple-negative breast cancer (TNBC) is a special subtype of breast cancer ...
Status
Recruiting
Location
Henan cancer hospital
Start Date
2022-12-20
Trial ID
NCT05475678
Treatments Being Tested
This study is intended to evaluate efficacy and safety of the combination o...
Status
Unknown
Location
Department of Medical Oncology, Shanghai Changzheng Hospital
Start Date
2019-03-01
Trial ID
NCT04110093
Treatments Being Tested
This research aims to assess both effectiveness and safety of combining R-G...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06611826
The objective of this study is to investigate the safety and tolerability o...
Status
Completed
Location
Cancer center of SunYat-sen University
Start Date
2023-04-27
Trial ID
NCT05742750
Treatments Being Tested